1. Home
  2. BBGI vs CTXR Comparison

BBGI vs CTXR Comparison

Compare BBGI & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beasley Broadcast Group Inc.

BBGI

Beasley Broadcast Group Inc.

N/A

Current Price

$5.67

Market Cap

11.5M

ML Signal

N/A

Logo Citius Pharmaceuticals Inc.

CTXR

Citius Pharmaceuticals Inc.

N/A

Current Price

$0.53

Market Cap

13.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BBGI
CTXR
Founded
1961
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.5M
13.4M
IPO Year
1999
2010

Fundamental Metrics

Financial Performance
Metric
BBGI
CTXR
Price
$5.67
$0.53
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
17.0K
★ 295.0K
Earning Date
11-13-2026
12-22-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 43.38
EPS
★ 48.01
N/A
Revenue
★ $232,179,463.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.47
$104.18
P/E Ratio
$0.12
★ N/A
Revenue Growth
★ 69.89
N/A
52 Week Low
$3.14
$0.37
52 Week High
$29.30
$1.54

Technical Indicators

Market Signals
Indicator
BBGI
CTXR
Relative Strength Index (RSI) 25.65 53.63
Support Level $3.50 $0.52
Resistance Level $24.70 $0.63
Average True Range (ATR) 0.63 0.07
MACD 0.24 0.00
Stochastic Oscillator 14.44 53.36

Price Performance

Historical Comparison
BBGI
CTXR

About BBGI Beasley Broadcast Group Inc.

Beasley Broadcast Group Inc is a multi-platform media company whose primary business is operating radio stations throughout the United States. The company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. It owns and operates stations in the following markets: Atlanta, GA; Augusta, GA; Boston, MA; Charlotte, NC; Detroit, MI; Fayetteville, NC; Fort Myers-Naples, FL; Las Vegas, NV; Middlesex, NJ; Monmouth, NJ; Morristown, NJ; Philadelphia, PA; Tampa-Saint Petersburg, FL; and Wilmington, DE. The company operates in two segments: Audio, which generates the maximum revenue, and Digital.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.

Share on Social Networks: